FR2730490B1 - Derives 1-(2-(vinyl-substitues))-3,4-dihydro-5h-2,3- benzodiazepine - Google Patents

Derives 1-(2-(vinyl-substitues))-3,4-dihydro-5h-2,3- benzodiazepine

Info

Publication number
FR2730490B1
FR2730490B1 FR9601551A FR9601551A FR2730490B1 FR 2730490 B1 FR2730490 B1 FR 2730490B1 FR 9601551 A FR9601551 A FR 9601551A FR 9601551 A FR9601551 A FR 9601551A FR 2730490 B1 FR2730490 B1 FR 2730490B1
Authority
FR
France
Prior art keywords
substitues
benzodiazepine
dihydro
vinyl
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9601551A
Other languages
English (en)
Other versions
FR2730490A1 (fr
Inventor
Pal Vago
Jozsef Reiter
Istvan Gyertyan
Gabor Gigler
Ferenc Andrasi
Anna Bakonyi
Pal Berzsenyi
Peter Botka
Faiglne Erzsebet Birkas
Tamas Hamori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of FR2730490A1 publication Critical patent/FR2730490A1/fr
Application granted granted Critical
Publication of FR2730490B1 publication Critical patent/FR2730490B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/02—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR9601551A 1995-02-09 1996-02-08 Derives 1-(2-(vinyl-substitues))-3,4-dihydro-5h-2,3- benzodiazepine Expired - Fee Related FR2730490B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9500386A HU224435B1 (hu) 1995-02-09 1995-02-09 Benzodiazepin-származékok, eljárás előállításukra, alkalmazásukra és ezeket tartalmazó gyógyászati készítmények

Publications (2)

Publication Number Publication Date
FR2730490A1 FR2730490A1 (fr) 1996-08-14
FR2730490B1 true FR2730490B1 (fr) 1997-04-18

Family

ID=10986432

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9601551A Expired - Fee Related FR2730490B1 (fr) 1995-02-09 1996-02-08 Derives 1-(2-(vinyl-substitues))-3,4-dihydro-5h-2,3- benzodiazepine

Country Status (18)

Country Link
US (1) US6075018A (fr)
JP (1) JP3354375B2 (fr)
KR (1) KR960031444A (fr)
BE (1) BE1009852A3 (fr)
CA (1) CA2169112A1 (fr)
CZ (1) CZ291218B6 (fr)
ES (1) ES2111492B1 (fr)
FI (1) FI960616A (fr)
FR (1) FR2730490B1 (fr)
GB (1) GB2297749B (fr)
HR (1) HRP960065A2 (fr)
HU (1) HU224435B1 (fr)
IT (1) IT1282591B1 (fr)
PL (1) PL312707A1 (fr)
RU (1) RU2155757C2 (fr)
SK (1) SK281482B6 (fr)
UA (1) UA45954C2 (fr)
YU (1) YU8396A (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649607B2 (en) 2001-05-18 2003-11-18 Vela Pharmaceuticals, Inc. Compositions and methods for treating or preventing convulsions or seizures
MXPA05005895A (es) * 2002-12-03 2006-02-08 Vela Pharmaceuticals Inc Composicion farmaceutica de 1-(3, 4-dimetoxifenil)-4 -metil-5-etil -7-metoxi-8 -hidroxi- 5h-2, 3-benzodiacepina y usos de la misma.
CA2510275A1 (fr) * 2002-12-03 2004-08-19 Vela Pharmaceuticals, Inc. Composition pharmaceutique de 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine et utilisations de celle-ci
US6864251B2 (en) * 2002-12-03 2005-03-08 Vela Pharmaceuticals, Inc. Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines
US6638928B1 (en) 2002-12-03 2003-10-28 Vela Pharmaceuticals, Inc. Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
US7022700B2 (en) * 2002-12-03 2006-04-04 Vela Pharmaceuticals, Inc. Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines
US20040152694A1 (en) * 2003-02-04 2004-08-05 Istvan Kurucz Methods and compositions for treating inflammatory disorders of the airways
US20040224943A1 (en) * 2003-02-19 2004-11-11 Leventer Steven M. Method of lowering body temperature with (R) - 2,3-benzodiazepines
PL1833815T3 (pl) * 2004-12-30 2011-03-31 Inst Farmaceutyczny Sposób wytwarzania zasady imatinibu
EP2338492A1 (fr) 2009-12-24 2011-06-29 Universidad del Pais Vasco Procédés et compositions pour le traitement de la maladie d'Alzheimer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE761315A (fr) * 1970-01-12 1971-07-07 S M B Anciens Etablissements J
HU179018B (en) * 1978-10-19 1982-08-28 Gyogyszerkutato Intezet Process for producing new 5h-2,3-benzodiazepine derivatives
HU186760B (en) * 1981-03-12 1985-09-30 Gyogyszerkutato Intezet Process for preparing 3,4-dihydro-5h-2,3-aenzodiazepine derivatives
HU195788B (en) * 1986-05-21 1988-07-28 Gyogyszerkutato Intezet Process for producing 1-/hydroxy-stiryl/-5h-2,3-benzobiazepines and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
PL312707A1 (en) 1996-08-19
UA45954C2 (uk) 2002-05-15
CA2169112A1 (fr) 1996-08-10
FI960616A0 (fi) 1996-02-09
HU224435B1 (hu) 2005-10-28
SK281482B6 (sk) 2001-04-09
FR2730490A1 (fr) 1996-08-14
YU8396A (sh) 1998-12-23
ES2111492B1 (es) 1999-07-01
ITMI960245A0 (fr) 1996-02-09
ITMI960245A1 (it) 1997-08-09
FI960616A (fi) 1996-08-10
HRP960065A2 (en) 1997-12-31
KR960031444A (ko) 1996-09-17
US6075018A (en) 2000-06-13
GB9602690D0 (en) 1996-04-10
GB2297749B (en) 1998-07-01
ES2111492A1 (es) 1998-03-01
JP3354375B2 (ja) 2002-12-09
GB2297749A (en) 1996-08-14
BE1009852A3 (fr) 1997-10-07
JPH08283247A (ja) 1996-10-29
SK16896A3 (en) 1996-10-02
CZ37796A3 (en) 1996-08-14
RU2155757C2 (ru) 2000-09-10
IT1282591B1 (it) 1998-03-31
CZ291218B6 (cs) 2003-01-15
HU9500386D0 (en) 1995-03-28

Similar Documents

Publication Publication Date Title
BR9611184A (pt) Derivados de 1-(1,2-Piperidinil dissubstituído)-4-piperazina substituída
TR199501463A2 (tr) Triazolil türevleri.
TR199600438A2 (tr) Piperazin türevleri.
NL300214I1 (nl) Chinazolinederivaten.
ATE226212T1 (de) 2-(purin-9-)-tetrahydrofuran-3,4-diol-derivate
DE69606721D1 (de) 1-(5-isochinolinsulfonyl)homopiperazin hydrochlorid
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
DE69809584D1 (de) Photochrome, carbocyclisch kondensierte naphthopyranderivate
TR199600883A2 (tr) Pürin-6-on türevleri.
BR9609849B1 (pt) derivados de 2-(4-substituìda) -benzilamino-2-metila-propanamida.
TR199501295A2 (tr) Apolipoprotein-b sentezi inhibitörleri.
ATE246199T1 (de) 3-descladinose-2,3-anhydroerythromycin-derivate
TR199600715A2 (tr) Kefalosforin türevleri.
FR2730490B1 (fr) Derives 1-(2-(vinyl-substitues))-3,4-dihydro-5h-2,3- benzodiazepine
DE69628458D1 (de) 25-hydroxy-16-ene-26,27-bishome-cholecalceriferol derivate
TR199600064A2 (tr) 4-amino-benzoilguanidin-türevleri.
DE59807563D1 (de) Substituierte 2-(3-alkenyl-benzoyl)-cyclohexan-1,3-dione
FR2730489B1 (fr) Derives de 1-(2-(vinyl-substitues))-5h-2,3-benzodiazepine
NO20015397L (no) 1,5-Benzodiazepin-derivater
ZA969927B (en) 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives.
ES1032571Y (es) Gafa,
FI954759A0 (fi) Foerfarande foer bestaemning av traedbestaondets maengd, taethet och kvalitet genom bildanalys
IT243100Y1 (it) Struttura di cerniera perfezionata,particolarmente per occhiali.
FI952416A0 (fi) Distributionsanordning foer vaetska, speciellt tvaettvaetska foer vindrutor
FI950956A0 (fi) Luftkabel, saosom haengspiralkabel

Legal Events

Date Code Title Description
ST Notification of lapse